GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiaceutics Share News (DXRX)

Share Price Information for Diaceutics (DXRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 129.00
Bid: 127.00
Ask: 131.00
Change: -1.50 (-1.15%)
Spread: 4.00 (3.15%)
Open: 130.50
High: 130.50
Low: 129.00
Prev. Close: 130.50
DXRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

EARNINGS AND TRADING: Michelmersh continues with positive order intake

Thu, 16th May 2024 14:32

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Guild Esports PLC - London-based esports business - Enters into fighting game series, Tekken. Signs Awais Liaqat as its first professional Tekken player. "Awais, who has signed a 12-month contract with Guild, is a seasoned Tekken professional and the first esports player to represent Pakistan at an international level," it says. Chief Executive Jasmine Skee says: "We have been waiting for the right time to enter Tekken, and with the upcoming Esports World Cup and the launch of Tekken 8, now is the perfect opportunity. It is testament to our esports prestige that we have been able to attract a player of Awais' calibre to Guild, and we look forward to seeing him compete in a Guild jersey."

----------

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Increases the number of enterprise-wide engagements it has with "top 20 global pharma customers" to six engagements from four, across 29 separate therapeutic brands. Enterprise-wide engagements currently represent annual recurring revenue of GBP9.0 million, GBP2.5 million of which relates to the two additional engagements. CEO Ryan Keeling comments: "The strength of our growing pipeline of new enterprise-level contracts highlights the progress we are making in becoming the primary commercialisation partner for pharma and biotech companies launching new precision medicines, validating the accelerated investment in our platform technology. These new engagements represent a significant step forward towards our core mission of getting every eligible patient the right test and the right therapy to positively impact their disease outcome."

----------

Michelmersh Brick Holdings PLC - Haywards Heath, West Sussex-based brick maker - Says it has continued to experience positive momentum in order intake. Explains that momentum reflects "the benefits of our product portfolio's broad reach and the strong customer loyalty and distributor relationships we have across our end markets". Says it remains mindful of the higher interest rate environment and its impact on demand across the wider construction industry. Looking ahead, expects to deliver full year trade in line with full-year expectations.

----------

Ilika PLC - Romsey, England-based solid-state battery technology company - Trading for year ended April 30 has been in line with management expectations. Expects revenue to be about GBP2.1 million, up from GBP700,000 a year earlier. Loss before interest, tax, depreciation and amortisation comes in at GBP4.5 million, narrowed from GBP7.0 million.

----------

Anglo Asian Mining PLC - Azerbaijan-focused gold, silver and copper producer - Revenue in 2023 fell to USD45.9 million from USD84.7 million, due to lower production. Notes pretax loss USD32.0 million from a profit of USD7.5 million. Operating loss of USD24.8 million, versus a profit of USD9.3 million. "Despite the adversity, good progress was achieved in 2023," the company says. "Anglo Asian remains confident in delivering its medium-term growth strategy to become a mid-tier copper-focused miner by 2028."

----------

Water Intelligence PLC - London-based leak detection services company - Revenue increases by 6% to USD20.5 million in quarter ended March 31 from USD19.4 million a year earlier. Pretax profit climbs 14% to USD2.0 million from USD1.8 million. Ebitda rises by 9% to USD3.5 million from USD3.2 million.

----------

Arecor Therapeutics PLC - West Sussex, England-based biopharmaceutical firm - Revenue in 2023 comes in at GBP5.7 million from GBP3.7 million a year earlier. Pretax loss narrows to GBP8.9 million from GBP10.4 million. CEO Sarah Howell says: "I believe the group is in a strong position and we are poised to deliver against a number of key milestones in 2024, in particular, completion of the Phase I trial of AT278 with results expected in H1."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
24 May 2024 11:08

DIRECTOR DEALINGS: Michael Ashcroft ups stake in Marlowe to 16%

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced this week and not separately reported by Alliance News:

Read more
21 May 2024 16:27

EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
16 May 2024 10:09

Diaceutics strikes two new enterprise-wide agreements

(Sharecast News) - Technology and solutions provider Diaceutics has struck two new enterprise-wide agreements, taking the total number to six engagements, across 29 separate therapeutic brands.

Read more
9 Apr 2024 12:34

Diaceutics appoints new VP of marketing

(Sharecast News) - Diaceutics, a technology and solutions provider catering to the pharmaceutical and biotech industry, announced the appointment of Amie Mc Neice as vice-president of marketing on Tuesday.

Read more
2 Apr 2024 19:02

TRADING UPDATES: Roadside shares suspended; Adnams looks for funds

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
21 Mar 2024 13:58

Diaceutics upgrades diagnositc commercialisation platform, DXRX

(Alliance News) - Diaceutics PLC on Thursday said it has launched a "significant upgrade" to its DXRX platform.

Read more
27 Feb 2024 14:18

TRADING UPDATES: Sondrel wins USD23 million contract

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
14 Feb 2024 13:52

IN BRIEF: Diaceutics announces new marketing partnership with KPMG

Diaceutics PLC - Belfast-based provider of diagnostic commercialisation services to pharmaceutical and biotechnology companies - Announces strategic alliance with KPMG LLC, which provides tax, audit and advisory services and commercialisation solutions for life sciences and healthcare companies. Diaceutics says the partnership will facilitate joint marketing of commercialisation solutions to life science customers for commercialisation of precision medicines.

Read more
30 Jan 2024 11:16

Diaceutics maintains "momentum" for year ahead on revenue rise in 2023

(Alliance News) - Diaceutics PLC on Tuesday highlighted the extent of market opportunities for its product, after seeing annual revenue rise despite tough macroeconomic conditions.

Read more
26 Sep 2023 11:37

Diaceutics revenue grows but loss widens, CEO Keeling to step down

(Alliance News) - Diaceutics PLC on Tuesday reported strong revenue growth in its first half despite a widened loss, as well as strong demand from new customers despite a cautious atmosphere in the pharmaceutical sector.

Read more
29 Aug 2023 13:16

IN BRIEF: Diaceutics launches daily alerts for DXRX platform

Diaceutics PLC - Belfast-based testing laboratories company - Launches daily alerts update for its DXRX Signal platform, which it says will allow clients to identify patients who previously weren't receiving "the most appropriate treatment" due to lack of timely data. Adds that it has identified over 46,000 patients this year for its biopharma clients.

Read more
25 Jul 2023 12:12

Diaceutics interim revenue jumps as order book grows to GBP24 million

(Alliance News) - Diaceutics PLC on Tuesday reaffirmed its full year outlook, after delivering revenue growth of 32% in the first six months of the year.

Read more
6 Jun 2023 13:47

Director dealings: BAT, Diaceutics execs make investments

(Sharecast News) - Among the list of director buys on Tuesday was British American Tobacco, after its chief executive picked up more than a quarter-of-a-million pounds worth of shares.

Read more
5 Jun 2023 11:09

IN BRIEF: Diaceutics shares surge on contract win with top US firm

Diaceutics PLC - Belfast-based testing laboratories company - Wins a three-year enterprise contract with an unnamed "top 10 global pharmaceutical company" based in the US. Says the contract will bring in USD10.1 million in revenue over its term, with options to "significantly" increase its scope and value. Revenue will be recognised monthly, with immediate effect. Says revenue will be recognised on a monthly basis. It will deliver a range of subscription data services via its DXRX platform.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.